Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas Disease.
Torrico F, Gascón J, Ortiz L, Pinto J, Rojas G, Palacios A, Barreira F, Blum B, Schijman AG, Vaillant M, Strub-Wourgaft N, Pinazo MJ, Bilbe G, Ribeiro I. Torrico F, et al. Among authors: barreira f. Clin Infect Dis. 2023 Feb 8;76(3):e1186-e1194. doi: 10.1093/cid/ciac579. Clin Infect Dis. 2023. PMID: 35925555 Free PMC article. Clinical Trial.
Response to `letter to the editor: 'Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America'´.
Alonso-Padilla J, Cortés-Serra N, Pinazo MJ, Bottazzi ME, Abril M, Barreira F, Sosa-Estani S, Hotez PJ, Gascón J. Alonso-Padilla J, et al. Among authors: barreira f. Expert Rev Anti Infect Ther. 2019 Sep;17(9):673-675. doi: 10.1080/14787210.2019.1649139. Epub 2019 Aug 6. Expert Rev Anti Infect Ther. 2019. PMID: 31361163 No abstract available.
Fixed vs adjusted-dose benznidazole for adults with chronic Chagas disease without cardiomyopathy: A systematic review and meta-analysis.
Ciapponi A, Barreira F, Perelli L, Bardach A, Gascón J, Molina I, Morillo C, Prado N, Riarte A, Torrico F, Ribeiro I, Villar JC, Sosa-Estani S. Ciapponi A, et al. Among authors: barreira f. PLoS Negl Trop Dis. 2020 Aug 17;14(8):e0008529. doi: 10.1371/journal.pntd.0008529. eCollection 2020 Aug. PLoS Negl Trop Dis. 2020. PMID: 32804966 Free PMC article.
New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial.
Torrico F, Gascón J, Barreira F, Blum B, Almeida IC, Alonso-Vega C, Barboza T, Bilbe G, Correia E, Garcia W, Ortiz L, Parrado R, Ramirez JC, Ribeiro I, Strub-Wourgaft N, Vaillant M, Sosa-Estani S; BENDITA study group. Torrico F, et al. Among authors: barreira f. Lancet Infect Dis. 2021 Aug;21(8):1129-1140. doi: 10.1016/S1473-3099(20)30844-6. Epub 2021 Apr 6. Lancet Infect Dis. 2021. PMID: 33836161 Free article. Clinical Trial.
The Chagas disease study landscape: A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing an individual participant-level data platform.
Maguire BJ, Dahal P, Rashan S, Ngu R, Boon A, Forsyth C, Strub-Wourgaft N, Chatelain E, Barreira F, Sosa-Estani S, Guérin PJ. Maguire BJ, et al. Among authors: barreira f. PLoS Negl Trop Dis. 2021 Aug 16;15(8):e0009697. doi: 10.1371/journal.pntd.0009697. eCollection 2021 Aug. PLoS Negl Trop Dis. 2021. PMID: 34398888 Free PMC article.
Direct evidence gap on fixed versus adjusted-dose benznidazole for adults with chronic Chagas disease without cardiomyopathy: Systematic review and individual patient data meta-analysis.
Ciapponi A, Barreira F, Perelli L, Bardach A, Gascón J, Molina I, Morillo C, Prado N, Riarte A, Torrico F, Villar JC, Reidel S, Gibbons L, Sosa-Estani S. Ciapponi A, et al. Among authors: barreira f. Trop Med Int Health. 2023 Jan;28(1):2-16. doi: 10.1111/tmi.13831. Epub 2022 Dec 1. Trop Med Int Health. 2023. PMID: 36420767 Free article. Review.
Efficacy and safety of fexinidazole for treatment of chronic indeterminate Chagas disease (FEXI-12): a multicentre, randomised, double-blind, phase 2 trial.
Pinazo MJ, Forsyth C, Losada I, Esteban ET, García-Rodríguez M, Villegas ML, Molina I, Crespillo-Andújar C, Gállego M, Ballart C, Ramirez JC, Aden T, Hoerauf A, Pfarr K, Vaillant M, Marques T, Fernandes J, Blum B, Ribeiro I, Sosa-Estani S, Barreira F, Gascón J; FEXI-12 Study Team. Pinazo MJ, et al. Among authors: barreira f. Lancet Infect Dis. 2024 Apr;24(4):395-403. doi: 10.1016/S1473-3099(23)00651-5. Epub 2024 Jan 11. Lancet Infect Dis. 2024. PMID: 38218194 Clinical Trial.
15 results